]>
IRCT20210613051561N1 IRCT 2021-06-21 Esfahan University of Medical Sciences Complications of pulmonary thromboembolism after rapid performance of the team responsible for pulmonary embolism Comparative study of the frequency of complications due to high-risk pulmonary thromboembolism after rapid performance of the team responsible for pulmonary embolism (TIMAR) compared to conventional performance 2021-08-05 anticipated 74 Complete https://irct.ir/trial/56863 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 2-3 Pulmonary embolism. Intervention 1: Intervention group: patients in this group, whose thromboembolism has been previously proven by CT scan and Geneva criteria, are visited and evaluated by a cardiology resident and treated if patients are at high risk for thromboembolism, they will be treated according to the protocol provided by the Timar team members and the treatment plan will be implemented within a maximum of 60 minutes. Mortality and treatment complications as well as cardiac function in patients after interventions will be measured by echocardiography and checklist. Intervention 2: Control group: patients in this group, as usual and according to hospital protocols, will be examined by a cardiology resident and their thromboembolism will be diagnosed by CT scan and Geneva criteria and will be treated by the cardiology service. Mortality and treatment complications as well as cardiac function in patients after interventions will be measured by echocardiography and checklist. Yes - There is a plan to make this available What will be shared: All data can be shared after people have requested. When: Six months after publishing the results. To whom: Academic researchers Conditions: Scientific uses Where to obtain: Website of the Research Committee of Isfahan University of Medical Sciences How to obtain: Clear request on the site to access the data by the individual and then review the request by the research assistant within 2 weeks and then allow access to the data. Comments:
public Mohammad Hadi Mansouri
No. 22, Roshd Ave., Daneshgah Blvd., Isfahan
Isfahan Iran (Islamic Republic of) 8174673461 +98 31 3668 0042 mansouri.hadi@gmail.com Esfahan University of Medical Sciences scientific Mohammad Hadi Mansouri
No. 22, Roshd Ave., Daneshgah Blvd., Isfahan
Isfahan Iran (Islamic Republic of) 8174673461 +98 31 3668 0042 mansouri.hadi@gmail.com Esfahan University of Medical Sciences Iran (Islamic Republic of) Age 18 to 75 years old Diagnosis of pulmonary thromboembolism based on the GENEVA criteria Patients with high-risk pulmonary embolism Satisfaction with entering this study 18 years 75 years Both Dissatisfaction to continue participation in the study I26 Pulmonary embolism Treatment - Other Treatment - Other Intervention group: patients in this group, whose thromboembolism has been previously proven by CT scan and Geneva criteria, are visited and evaluated by a cardiology resident and treated if patients are at high risk for thromboembolism, they will be treated according to the protocol provided by the Timar team members and the treatment plan will be implemented within a maximum of 60 minutes. Mortality and treatment complications as well as cardiac function in patients after interventions will be measured by echocardiography and checklist. Control group: patients in this group, as usual and according to hospital protocols, will be examined by a cardiology resident and their thromboembolism will be diagnosed by CT scan and Geneva criteria and will be treated by the cardiology service. Mortality and treatment complications as well as cardiac function in patients after interventions will be measured by echocardiography and checklist. Mortality rate. Timepoint: After interventions. Method of measurement: Check list. Time of hospitalization. Timepoint: After interventions. Method of measurement: Check list. Heart function. Timepoint: After interventions. Method of measurement: Eco cardiography. Esfahan University of Medical Sciences Approved 2019-10-14 Ethics committee of Esfahan university of Medical sciences No. 18, Hezar Jarib Ave., Daneshgah Blvd., Isfahan Isfahan Isfehan Iran (Islamic Republic of)